Source: Empower Clinics Inc.
  • Empower Clinics (CBDT) will be conducting a non-brokered private placement for aggregate gross proceeds of up to $3,000,000
  • The company will issue units at a price of $0.20 and unsecured convertible debenture units at a price of $1,000 per unit
  • Each debenture unit will consist of one senior unsecured convertible debenture and 5,000 warrants
  • The debentures will pay 6 per cent interest per annum and will mature two years from the date of issuance
  • Empower is a healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care
  • Empower Clinics Inc. (CBDT) is up 5.48 per cent, trading at C$0.385 per share at 10:35 am EST

Empower Clinics (CBDT) will be conducting a non-brokered private placement for aggregate gross proceeds of up to $3,000,000.

The company will issue units at a price of $0.20 and unsecured convertible debenture units at a price of $1,000 per unit.

Each unit will consist of one common share and one common share purchase warrant. Each warrant will entitle the holder to purchase one share at a price of $0.30 for a period of two years.

Each debenture unit will consist of one senior unsecured convertible debenture and 5,000 warrants. The debentures will bear interest at the rate of 6.0 per cent per annum and will mature two years from the date of issuance. The debentures may be converted into shares at any time prior to the maturity date at a conversion price of $0.20 per share.

The closing of the offering will occur on or about January 6th and is subject to receipt of all necessary corporate and regulatory approvals.

Proceeds will be used for advancing the company’s growth plans, working capital purposes and general administrative expenses.

Units and debentures issued in connection with the financing will be subject to a four-month hold period under applicable Canadian securities laws.

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Empower is aggressively growing its clinical and digital presence across North America.

Empower Clinics Inc. (CBDT) is up 5.48 per cent, trading at C$0.385 per share at 10:35 am EST.

More From The Market Online
pharmather logo

PharmaTher receives FDA priority review for ketamine new drug application

PharmaTher (CSE:PHRM) has received a letter from the U.S. Food and Drug Administration (FDA) for its new drug application for ketamine.
Knee osteoarthritis concept

NeuPath Health brings top osteoarthritis treatment to Canada

NeuPath Health (TSXV:NPTH) administers the first injection of Arthrosamid in North America at its Mississauga, Ontario clinic.
ai generated stock image

Buzz on the Bullboards: Stocks making headlines – Baytex, New Found Gold, Theralase

Canada’s main stock index rallied following reports that the US administration was considering relaxing the strict tariffs.